Abstract

To generate functional human hepatocytes from stem cells and/or extra-hepatic tissues could provide an important source of cells for treating liver diseases. Spermatogonial stem cells (SSCs) have an unlimited plasticity since they can dedifferentiate and transdifferentiate to other cell lineages. However, generation of mature and functional hepatocytes from human SSCs has not yet been achieved. Here we have for the first time reported direct transdifferentiation of human SSCs to mature and functional hepatocytes by three-step induction using the defined condition medium. Human SSCs were first transdifferentiated to hepatic stem cells, as evidenced by their morphology and biopotential nature of co-expressing hepatocyte and cholangiocyte markers but not hallmarks for embryonic stem cells. Hepatic stem cells were further induced to differentiate into mature hepatocytes identified by their morphological traits and strong expression of CK8, CK18, ALB, AAT, TF, TAT, and cytochrome enzymes rather than CK7 or CK19. Significantly, mature hepatocytes derived from human SSCs assumed functional attributes of human hepatocytes, because they could produce albumin, remove ammonia, and uptake and release indocyanine green. Moreover, expression of β-CATENIN, HNF4A, FOXA1 and GATA4 was upregulated during the transdifferentiation of human SSCs to mature hepatocytes. Collectively, human SSCs could directly transdifferentiate to mature and functional hepatocytes. This study could offer an invaluable source of human hepatocytes for curing liver disorders and drug toxicology screening and provide novel insights into mechanisms underlying human liver regeneration.

Highlights

  • Allogeneic liver transplantation has been regarded as an effective treatment for the end-stage and inherited liver diseases [1, 2]

  • We proposed a novel concept that human Spermatogonial stem cells (SSCs) can directly transdifferentiate to mature and functional hepatocytes, which achieved two significant endpoints

  • The conversion of human SSCs to hepatic stem cells was relatively efficient using our induction procedure compared to human embryonic stem (ES) cells or induced pluripotent stem (iPS) cells, because more than 80% of human SSCs could be converted into human hepatic stem cells, as evidenced by our double immunostaining and flow cytometry analyses

Read more

Summary

Introduction

Allogeneic liver transplantation has been regarded as an effective treatment for the end-stage and inherited liver diseases [1, 2]. The availability of primary human hepatocytes is rather limited, and these cells are hard to proliferate and have short-term viability in vitro [7]. It is urgently www.impactjournals.com/oncotarget required to seek an ideal cell source from stem cells and/ or extra-liver tissues to generate mature and functional human hepatocytes for treating patients with the endstage and/or inherited liver diseases. In addition to the therapeutic application, generation of human hepatocytes from stem cells and human other tissues could be utilized for liver disease modeling as well as drug and toxicity screening

Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call